BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 9735486)

  • 1. Successful immunotherapy. A partnership between consultant and general practitioner.
    Katelaris CH
    Aust Fam Physician; 1998 Aug; 27(8):687-92. PubMed ID: 9735486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Preventive immunotherapy].
    Boquete M; Carballada F; Expósito F; González A
    Allergol Immunopathol (Madr); 2000; 28(3):89-93. PubMed ID: 10867376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sublingual immunotherapy for children: Are we there yet? Defining its role in clinical practice.
    Campbell DE
    Paediatr Respir Rev; 2009 Jun; 10(2):69-74; quiz 74. PubMed ID: 19410205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for adverse systemic reactions occurring during immunotherapy with standardized Dermatophagoides farinae extracts.
    Ohashi Y; Nakai Y; Tanaka A; Kakinoki Y; Washio Y; Ohno Y; Yamada K; Nasako Y
    Acta Otolaryngol Suppl; 1998; 538():113-7. PubMed ID: 9879410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of specific immunotherapy with Grazax in allergic rhinitis co-existing with asthma.
    Nasser S; Vestenbaek U; Beriot-Mathiot A; Poulsen PB
    Allergy; 2008 Dec; 63(12):1624-9. PubMed ID: 19032235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of specific immunotherapy with SQ allergen extract in treatment-resistant seasonal allergic rhinoconjunctivitis.
    Frew AJ; Powell RJ; Corrigan CJ; Durham SR;
    J Allergy Clin Immunol; 2006 Feb; 117(2):319-25. PubMed ID: 16461133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiallergen immunotherapy for allergic rhinitis and asthma.
    Nelson HS
    J Allergy Clin Immunol; 2009 Apr; 123(4):763-9. PubMed ID: 19217653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific allergy immunotherapy for allergic rhinitis: subcutaneous and sublingual.
    Cox L; Wallace D
    Immunol Allergy Clin North Am; 2011 Aug; 31(3):561-99. PubMed ID: 21737043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sublingual immunotherapy in the treatment of adult allergic rhinitis patients.
    Canonica GW; Passalacqua G
    Allergy; 2006; 61 Suppl 81():20-3. PubMed ID: 16792602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of the pediatric aspects of the WHO document and meta-analysis of immunotherapy].
    Ibáñez Sendín MD
    Allergol Immunopathol (Madr); 2000; 28(3):82-9. PubMed ID: 10867375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Safety of immunotherapy and skin tests with allergens in children younger than five years].
    Rodríguez Pérez N; Ambriz Moreno Mde J
    Rev Alerg Mex; 2006; 53(2):47-51. PubMed ID: 16884027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy: first do no harm.
    Moss MH
    Immunol Allergy Clin North Am; 2005 May; 25(2):421-39, viii. PubMed ID: 15878464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omalizumab pretreatment decreases acute reactions after rush immunotherapy for ragweed-induced seasonal allergic rhinitis.
    Casale TB; Busse WW; Kline JN; Ballas ZK; Moss MH; Townley RG; Mokhtarani M; Seyfert-Margolis V; Asare A; Bateman K; Deniz Y;
    J Allergy Clin Immunol; 2006 Jan; 117(1):134-40. PubMed ID: 16387596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utilization and cost of immunotherapy for allergic asthma and rhinitis.
    Donahue JG; Greineder DK; Connor-Lacke L; Canning CF; Platt R
    Ann Allergy Asthma Immunol; 1999 Apr; 82(4):339-47. PubMed ID: 10227332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Safety analysis of dust mite allergen for diagnosis and immunotherapy of asthma and rhinitis].
    Wen T; Cai Y; Chen X; Xiang L; Wang B; Zhuang Y
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1999; 17(5):274-6. PubMed ID: 12563856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost effectiveness of sublingual immunotherapy in children with allergic rhinitis and asthma.
    Berto P; Bassi M; Incorvaia C; Frati F; Puccinelli P; Giaquinto C; Cantarutti L; Ortolani C
    Eur Ann Allergy Clin Immunol; 2005 Oct; 37(8):303-8. PubMed ID: 17066648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anaphylaxis caused by allergen sublingual immunotherapy?
    André C; Fadel R
    Allergy; 2007 Oct; 62(10):1220-1. PubMed ID: 17845597
    [No Abstract]   [Full Text] [Related]  

  • 18. Seasonal allergic rhinitis: limited effectiveness of treatments.
    Prescrire Int; 2008 Feb; 17(93):28-32. PubMed ID: 18383656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of allergen immunotherapy in the treatment of allergic rhinitis and asthma in real life.
    Zeldin Y; Weiler Z; Magen E; Tiosano L; Kidon MI
    Isr Med Assoc J; 2008 Dec; 10(12):869-72. PubMed ID: 19160945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The health economics of allergen immunotherapy.
    Hankin CS; Cox L; Bronstone A
    Immunol Allergy Clin North Am; 2011 May; 31(2):325-41, x. PubMed ID: 21530823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.